A 2024 meta-analysis of 18 randomized trials found a small mortality signal for ultrasound-guided resuscitation. The signal is real but narrow, rests largely on small trials, and arrives without a clear explanation of what the ultrasound changed.
VERIFIEDBasmaji et al., Crit Care Med 2024SR/MA · 18 RCTs · GRADE
The mortality interval clears 1.0 by a hundredth. The renal replacement therapy interval does not clear it at all.
01
The review
Design
Systematic review and meta-analysis, RCTs only
Trials
18 RCTs, searched through December 2023
Population
Adults with shock of any cause; mostly small trials
Comparison
POCUS-guided resuscitation vs care without it
−0.73 d
Vasoactive drug duration (95% CI −1.16 to −0.30)
High
Certainty that lactate clearance improves, the only high-certainty benefit
02
Caption vs paper
Claim in the circulating post
What the review found
Certainty
Verdict
Reduced 28-day mortality
RR 0.88 (0.78–0.99); "probably reduces"
–
Supported, narrowly
Shorter vasoactive duration
About three-quarters of a day shorter
–
Supported
Improved lactate clearance
Improved; a surrogate, not an outcome
Supported
↓ Need for RRT
RR 0.80 (0.63–1.02); the interval includes no effect
–
Overstated
In undifferentiated shock
Pooled across shock settings; the one ED undifferentiated-hypotension RCT was neutral (section 04)
—
Overstated
"Smarter resuscitation"
POCUS shifted plans slightly but produced little to no change in fluid or inotrope actually given
–
Mechanism unclear
Certainty dots follow the review's GRADE ratings: one dot very low, four high. Ranges reflect the abstract's grouped ratings.
03
What did not change
ICU and hospital admissions, and ICU and hospital length of stay (little to no difference).
Need for mechanical ventilation (little to no difference).
Number of CT scans (may be no change); diagnostic echocardiograms probably decreased.
Acute kidney injury and duration of ventilation or RRT (very low certainty; effect uncertain).
The puzzle. Mortality moved, but the fluids and inotropes delivered barely did. Either the benefit runs through decisions the trials did not measure, such as earlier source control or a corrected diagnosis, or the mortality signal is less robust than its interval suggests. The review cannot say which.
04
The ED question
The trial closest to "undifferentiated shock in the emergency department" is SHoC-ED: 273 hypotensive ED patients across six centers in North America and South Africa, randomized to an early POCUS protocol or standard care. Survival to 30 days or discharge was essentially identical (104/136 vs 102/134; difference 0.35%, 95% CI −10.2% to 11.0%), and a later report found no difference in shock index, lactate, or bicarbonate at four hours.
SHoC-ED was small and cannot exclude benefit. It does mean the strongest ED-specific trial is neutral, and the pooled mortality signal comes from the other trials.
05
At the bedside
Use POCUS in shock. The pooled evidence leans toward benefit and away from harm, and it reliably answers questions an exam cannot: tamponade, RV failure, a hyperdynamic empty heart, gross LV dysfunction.
Expect it to sharpen decisions, not to replace them. The benefit depends on what you do with the image.
Do not cite it as proof that POCUS reduces dialysis; that estimate crosses no effect.
Do not quote the mortality effect as settled. A relative risk of 0.88 with an upper bound of 0.99 is a probable small benefit at low-to-moderate certainty.
Case seriesSingle RCTMA of small RCTsLarge multicenter RCTGuideline
06
Sources
Basmaji J, Arntfield R, Desai K, et al. The impact of point-of-care ultrasound-guided resuscitation on clinical outcomes in patients with shock: a systematic review and meta-analysis. Crit Care Med. 2024;52(11):1661-1673. doi:10.1097/CCM.0000000000006399
Atkinson PR, Milne J, Diegelmann L, et al. Does point-of-care ultrasonography improve clinical outcomes in emergency department patients with undifferentiated hypotension? An international randomized controlled trial from the SHoC-ED investigators. Ann Emerg Med. 2018;72(4):478-489. doi:10.1016/j.annemergmed.2018.04.002
Atkinson P, Taylor L, Milne J, et al. Does point of care ultrasound improve resuscitation markers in undifferentiated hypotension? An international randomized controlled trial from the SHoC-ED series. Cureus. 2020;12(8):e9899. doi:10.7759/cureus.9899
Karnicki C. POCUS use in shock resuscitation: evidence for patient and system-level benefits. REBEL EM, January 5, 2026.